Patents by Inventor Larry C. Blaszczak

Larry C. Blaszczak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030236243
    Abstract: 6(7)-&bgr;-substituted &bgr;-lactam compounds as inhibitors of &bgr;-lactamase activity.
    Type: Application
    Filed: May 14, 2003
    Publication date: December 25, 2003
    Inventors: Brian K. Shoichet, Larry C. Blaszczak
  • Patent number: 5453502
    Abstract: The invention provides 1,3,4 substituted and bicyclic derivatives of 2-azetidinones and processes therefor. These compounds are valuable intermediates useful in the preparation of 1-carba(dethia)cephalosporin antibiotics.
    Type: Grant
    Filed: March 16, 1994
    Date of Patent: September 26, 1995
    Assignee: Eli Lilly and Company
    Inventors: James A. Aikins, Larry C. Blaszczak, Kevin P. Lund, John R. Rizzo
  • Patent number: 5393882
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.
    Type: Grant
    Filed: February 24, 1993
    Date of Patent: February 28, 1995
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 5239068
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.
    Type: Grant
    Filed: April 20, 1992
    Date of Patent: August 24, 1993
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 5142039
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with a more desirable protecting group.
    Type: Grant
    Filed: September 26, 1990
    Date of Patent: August 25, 1992
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 5037975
    Abstract: The invention provides a free radical process for preparing 1-carba(1-dethia)cephalosporin antibiotics with 2-substituted methylcephalosporin 1,1-dioxides wherein the substituent on the 2-methylene group is a free radical precursor group such as a phenyl or alkylseleno group. The latter dioxides are treated with a free radical initiator, e.g., a trialkyltin hydride or actinic radiation at 40.degree. C. to 150.degree. C. to provide the 1-carba-3-cephem and 1-carba-2-cephem products. The invention also provides free radical compounds formed as intermediates in the process.
    Type: Grant
    Filed: March 28, 1990
    Date of Patent: August 6, 1991
    Assignee: Eli Lilly and Company
    Inventor: Larry C. Blaszczak
  • Patent number: 4983732
    Abstract: A method for preparing 2-amino-.beta.-lactams which are substituted by readily-removed protecting groups is provided. According to this invention, an acyl-2-amino-.beta.-lactam is further acylated with a different acyl group and is subsequently treated with base to provide a protected 2-amino .beta.-lactam with allyloxycarbonyl, t-butoxycarbonyl, naphthyloxycarbonyl, trichloroethyloxycarbonyl, p-nitrobenzyloxycarbonyl, benzhydryloxycarbonyl, p-methoxybenzyloxycarbonyl, or o-nitrobenzyloxycarbonyl.
    Type: Grant
    Filed: September 21, 1989
    Date of Patent: January 8, 1991
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, John E. Munroe, Douglas O. Spry
  • Patent number: 4939249
    Abstract: The invention provides a free radical process for preparing 1-carba(1-dethia)cephalosporin antibiotics represented by the formula ##STR1## wherein R is amino or protected amino, R.sub.1 is H or alkoxy, R.sub.3 is H or alkyl, Z is ##STR2## where R.sub.2 is, e.g., H, halogen, or alkyl, or --CH.sub.2 R.sub.2 ' where R.sub.2 ' is, e.g., hydroxy, methoxy, or heterocyclicthio group, and A is a carboxy-protecting group which comprises heating a 2-substituted-methylcephalosporin 1,1-dioxide of the formula ##STR3## wherein R, R.sub.1, R.sub.3, and A are the same as in the formula above and Y is a free radical precursor group, e.g., C.sub.1 -C.sub.6 --Se--, C.sub.1 -C.sub.6 --S--, or phenyl--Se--; with a free radical initiator, e.g., a trialkyltin hydride, radiation, or a cobalt I salophen. Also provided are free radical compounds formed as intermediates in the process.
    Type: Grant
    Filed: September 16, 1988
    Date of Patent: July 3, 1990
    Assignee: Eli Lilly and Company
    Inventor: Larry C. Blaszczak
  • Patent number: 4918185
    Abstract: This invention relates to certain 3-acylamino-4-(2'-substituted or unsubstituted allyl)-azetidinone products of the formula ##STR1## wherein R.sub.12 is an acyl group;R.sub.13 is hydrogen or methoxy;R.sub.14 is hydrogen, C.sub.1 to C.sub.6 alkyl or cycloalkyl, phenyl, phenyl-C.sub.1 to C.sub.4 alkyl or (protected carboxy)-methyl; andR.sub.15 is hydrogen or an amino protecting group.
    Type: Grant
    Filed: May 19, 1988
    Date of Patent: April 17, 1990
    Assignee: Eli Lilly and Company
    Inventor: Larry C. Blaszczak
  • Patent number: 4771135
    Abstract: The invention encompasses a process for stereoselective carbon-carbon bond formation at C-4 position of a 3-(acylamino)azetidinone. The process is carried out under free radical conditions using a (2-substituted or unsubstituted allyl)tin reagent. Also encompassed by the invention are certain 4-(substituted selenyl)azetidinone starting materials and the corresponding 4-(2'-substituted or unsubstituted allyl)-azetidinone products.
    Type: Grant
    Filed: September 22, 1987
    Date of Patent: September 13, 1988
    Assignee: Eli Lilly and Company
    Inventor: Larry C. Blaszczak
  • Patent number: 4492694
    Abstract: 7-(3-Indolyl)glycylamido cephalosporins have good gram positive activity and favorable pharmacokinetics and are orally effective.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: January 8, 1985
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, Jan R. Turner
  • Patent number: 4492693
    Abstract: 7-(3-Benzothienyl)glycylamido cephalosporins have good gram positive activity and favorable pharmacokinetics and are orally effective.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: January 8, 1985
    Assignee: Eli Lilly and Company
    Inventors: Larry C. Blaszczak, Stjepan Kukolja, Jan R. Turner
  • Patent number: 4490370
    Abstract: Naphthylglycyl and tetrahydronaphthylglycyl cephalosporins are potent antibacterial agents and are particularly useful as oral treatments for upper respiratory infections.
    Type: Grant
    Filed: April 12, 1983
    Date of Patent: December 25, 1984
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Larry C. Blaszczak, Jan R. Turner
  • Patent number: 4320055
    Abstract: 6.beta.-acylaminopenicillin-1.beta.-sulfoxides are epimerized to 6.alpha.-acylaminopenicillin-1.beta.-sulfoxides using triethylamine and chlorotrimethylsilane. The 6.alpha.-acylaminopenicillin-1.beta.-sulfoxides produced in this process are useful intermediates in the synthesis of 7.beta.-acylamino-7.alpha.-alkoxy-3-methyl 1-oxa .beta.-lactam acids, a class of 1-oxa .beta.-lactam antibiotics.
    Type: Grant
    Filed: April 7, 1980
    Date of Patent: March 16, 1982
    Assignee: Eli Lilly and Company
    Inventor: Larry C. Blaszczak
  • Patent number: 4271305
    Abstract: Novel halogenating compounds, derived from triaryl phosphites and chlorine or bromine are employed to convert 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives. The product 3-halo-3-cephems are antibiotic compounds or intermediates thereto.
    Type: Grant
    Filed: December 14, 1979
    Date of Patent: June 2, 1981
    Assignee: Eli Lilly and Company
    Inventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher
  • Patent number: 4230644
    Abstract: Novel halogenating agents are derived from triaryl phosphites and chlorine or bromine. They are useful in converting 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives.
    Type: Grant
    Filed: February 1, 1979
    Date of Patent: October 28, 1980
    Assignee: Eli Lilly and Company
    Inventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher
  • Patent number: 4226986
    Abstract: Novel halogenating compounds, derived from triaryl phosphites and chlorine or bromine are employed to convert 7-acylamino-3-hydroxy-3-cephem compounds to 7-acylamino-3-halo-3-cephems and the corresponding C-7 imino halide cephem derivatives. The product 3-halo-3-cephems are antibiotic compounds or intermediates thereto.
    Type: Grant
    Filed: February 1, 1979
    Date of Patent: October 7, 1980
    Assignee: Eli Lilly and Company
    Inventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher
  • Patent number: 4211702
    Abstract: Penicillin and cephalosporin imino halides are prepared by reacting of 6-acylaminopenicillins or 7-acylamino cephalosporins with a novel chlorinating compound derived from a triaryl phosphite and chlorine or bromine. The imino halide products are intermediates in the preparation of antibiotic compounds.
    Type: Grant
    Filed: February 1, 1979
    Date of Patent: July 8, 1980
    Assignee: Eli Lilly and Company
    Inventors: Lowell D. Hatfield, Larry C. Blaszczak, Jack W. Fisher